49
Views
2
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

High-grade glioma: elderly patients, older treatments

, , , &
Pages 1293-1296 | Published online: 09 Jan 2014

References

  • Brandes AA, Franceschi E, Tosoni A et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115(15), 3512–3518 (2009).
  • Barker CA, Chang M, Chou JF et al. Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J. Neurooncol. 109(2), 391–397 (2012).
  • Stupp R, Hegi ME, Mason WP et al.; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC–NCIC trial. Lancet Oncol. 10(5), 459–466 (2009).
  • Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE. Patterns of care in elderly glioblastoma patients. Ann. Neurol. 64(6), 628–634 (2008).
  • Laperriere N, Weller M, Stupp R et al. Optimal management of elderly patients with glioblastoma. Cancer Treat. Rev. (2012).
  • Mangiola A, Maira G, De Bonis P et al. Glioblastoma multiforme in the elderly: a therapeutic challenge. J. Neurooncol. 76(2), 159–163 (2006).
  • Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J. Debulking or biopsy of malignant glioma in elderly people – a randomised study. Acta Neurochir. (Wien). 145(1), 5–10 (2003).
  • Chaichana KL, Garzon-Muvdi T, Parker S et al. Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann. Surg. Oncol. 18(1), 239–245 (2011).
  • Keime-Guibert F, Chinot O, Taillandier L et al.; Association of French-Speaking Neuro-Oncologists. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med. 356(15), 1527–1535 (2007).
  • Scott J, Tsai YY, Chinnaiyan P, Yu HH. Effectiveness of radiotherapy for elderly patients with glioblastoma. Int. J. Radiat. Oncol. Biol. Phys. 81(1), 206–210 (2011).
  • Balducci M, Fiorentino A, De Bonis P et al. Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional Phase II studies. Med. Oncol. 29(5), 3478–3483 (2012).
  • Minniti G, Lanzetta G, Scaringi C et al. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int. J. Radiat. Oncol. Biol. Phys. 83(1), 93–99 (2012).
  • Scott JG, Suh JH, Elson P et al. Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol. 13(4), 428–436 (2011).
  • Wick W, Platten M, Meisner C et al.; NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, Phase 3 trial. Lancet Oncol. 13(7), 707–715 (2012).
  • Malmstrom AG, Grønberg BH, Stupp R et al. Glioblastoma (GBM) in elderly patients: a randomized Phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). J. Clin. Oncol. 18s (2010) (Abstract LBA2002).
  • Gállego Pérez-Larraya J, Ducray F, Chinot O et al. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF Phase II trial. J. Clin. Oncol. 29(22), 3050–3055 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.